These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 7357526)

  • 41. Hodgkin's disease in Western India: review of 1082 cases.
    Talvalkar GV; Sampat MB; Gangadharan P
    Cancer; 1982 Jul; 50(2):353-9. PubMed ID: 7083142
    [TBL] [Abstract][Full Text] [Related]  

  • 42. A comparative study of the nodular and diffuse variants of lymphocyte-predominant Hodgkin's disease.
    Borg-Grech A; Radford JA; Crowther D; Swindell R; Harris M
    J Clin Oncol; 1989 Sep; 7(9):1303-9. PubMed ID: 2769329
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Risk patterns of Hodgkin's disease in Los Angeles vary by cell type.
    Cozen W; Katz J; Mack TM
    Cancer Epidemiol Biomarkers Prev; 1992; 1(4):261-8. PubMed ID: 1303125
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinico-pathological study of Hodgkin's lymphoma in a cancer center in Taiwan.
    Lee MY; Tan TD; Feng AC
    Clin Lab Haematol; 2005 Dec; 27(6):379-83. PubMed ID: 16307539
    [TBL] [Abstract][Full Text] [Related]  

  • 45. A pathologic study of Hodgkin's disease in Korea and its association with Epstein-Barr virus infection.
    Huh J; Park C; Juhng S; Kim CE; Poppema S; Kim C
    Cancer; 1996 Mar; 77(5):949-55. PubMed ID: 8608489
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hodgkin's disease. A clinico-pathological study of 250 cases with a 5-year follow-up.
    Newton KA; Mackenzie DH; Spittle MF; Mikolajczuk A
    Br J Cancer; 1973 Jan; 27(1):80-91. PubMed ID: 4510179
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Nucleoli and AgNORs in Hodgkin's disease.
    Mamaev NN; Medvedeva NV; Shust VF; Markochev AB; Pasternak ND
    Mol Pathol; 1997 Jun; 50(3):149-52. PubMed ID: 9292150
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Epstein-Barr virus (EBV) and Hodgkin's disease in children: incidence of EBV latent membrane protein in malignant cells.
    Weinreb M; Day PJ; Murray PG; Raafat F; Crocker J; Parkes SE; Coad NA; Jones JT; Mann JR
    J Pathol; 1992 Dec; 168(4):365-9. PubMed ID: 1336543
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Expression of cell adhesion molecules associated with germinal center in Hodgkin's disease: an immunohistochemical study. The germinal center related complex and histologic subtypes.
    Ree HJ; Khan AA; Qureshi MN; Teplitz C
    Cancer; 1994 Feb; 73(4):1257-63. PubMed ID: 7906194
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [A clinicopathological study of nodular lymphocyte predominance Hodgkin's disease].
    Deng F; Liu X; Tang W
    Zhonghua Xue Ye Xue Za Zhi; 1999 May; 20(5):239-41. PubMed ID: 11601211
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Florid progressive transformation of germinal centers. A syndrome affecting young men, without early progression to nodular lymphocyte predominance Hodgkin's disease.
    Ferry JA; Zukerberg LR; Harris NL
    Am J Surg Pathol; 1992 Mar; 16(3):252-8. PubMed ID: 1599017
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Hodgkin lymphoma: clinicopathologic features in Benin City, Nigeria and update on its biology and classification.
    Olu-Eddo AN; Omoti CE
    Niger J Clin Pract; 2011; 14(4):440-4. PubMed ID: 22248946
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Clinical presentation, course, and prognostic factors in lymphocyte-predominant Hodgkin's disease and lymphocyte-rich classical Hodgkin's disease: report from the European Task Force on Lymphoma Project on Lymphocyte-Predominant Hodgkin's Disease.
    Diehl V; Sextro M; Franklin J; Hansmann ML; Harris N; Jaffe E; Poppema S; Harris M; Franssila K; van Krieken J; Marafioti T; Anagnostopoulos I; Stein H
    J Clin Oncol; 1999 Mar; 17(3):776-83. PubMed ID: 10071266
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Infradiaphragmatic presentation of Hodgkin's disease.
    Barrett A; Gregor A; McElwain TJ; Peckham MJ
    Clin Radiol; 1981 Mar; 32(2):221-4. PubMed ID: 7214839
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Epidemiological surveillance of pediatric Hodgkin's disease in southern Iran.
    Karimi M; Yarmohammadi H; Ghavanini AA; Kumar PV
    Med Sci Monit; 2002 Aug; 8(8):CR572-5. PubMed ID: 12165744
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Follicular dendritic cells in Hodgkin's disease.
    Alavaikko MJ; Hansmann ML; Nebendahl C; Parwaresch MR; Lennert K
    Am J Clin Pathol; 1991 Feb; 95(2):194-200. PubMed ID: 1992609
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Significance of cell proliferation index in assessing histological prognostic categories in Hodgkin's disease. An immunohistochemical study with Ki67 and MIB-1 monoclonal antibodies.
    Abele MC; Valente G; Kerim S; Navone R; Onesti P; Chiusa L; Resegotti L; Palestro G
    Haematologica; 1997; 82(3):281-5. PubMed ID: 9234572
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Hodgkin's disease in Mexico. Prevalence of Epstein-Barr virus sequences and correlations with histologic subtype.
    Zarate-Osorno A; Roman LN; Kingma DW; Meneses-Garcia A; Jaffe ES
    Cancer; 1995 Mar; 75(6):1360-6. PubMed ID: 7882287
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Bone marrow manifestations of Hodgkin's disease.
    O'Carroll DI; McKenna RW; Brunning RD
    Cancer; 1976 Oct; 38(4):1717-28. PubMed ID: 991090
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Extracellular deposition of eosinophil granule major basic protein in lymph nodes of patients with Hodgkin's disease.
    Butterfield JH; Kephart GM; Banks PM; Gleich GJ
    Blood; 1986 Dec; 68(6):1250-6. PubMed ID: 3535925
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.